Polaris Partners operates three specialized funds under one platform—core venture for healthcare and life sciences, a growth fund exclusively for profitable founder-owned B2B SaaS companies with $4-20M revenue who want to retain significant ownership, and an innovation fund that systematically turns academic biomedical research into companies with help from world-class scientists. With nearly 30 years focused heavily on healthcare, the firm has backed 400+ companies and helped bring 50+ therapies to market, while building a cross-Atlantic and Asia-Europe bridge for biotech formation through offices like 65LAB in Singapore.